Publications by authors named "Stella Breuer"

Article Synopsis
  • The CeTeG/NOA-09 trial found that combining CCNU with temozolomide significantly improved survival in newly diagnosed glioblastoma patients, increasing average survival from 31.4 months to 48.1 months.
  • A retrospective analysis of 70 patients receiving CCNU and temozolomide showed a median overall survival of 33.8 months and identified prolonged progression-free survival for those who also underwent TTFields treatment for at least eight weeks.
  • The study concluded that real-life outcomes for toxicity and survival are similar to the original trial, emphasizing that long-term TTFields therapy combined with CCNU and temozolomide is beneficial.
View Article and Find Full Text PDF

Purpose: Non-invasive prediction of the tumour of origin giving rise to brain metastases (BMs) using MRI measurements obtained in radiological routine and elucidating the biological basis by matched histopathological analysis.

Methods: Preoperative MRI and histological parameters of 95 BM patients (female, 50; mean age 59.6 ± 11.

View Article and Find Full Text PDF

Purpose: Hypertrophic olivary degeneration (HOD) is a pathology of the inferior olivary nucleus (ION) that occurs after injuries to the Guillain-Mollaret triangle (GMT). Lacking a diagnostic gold standard, diagnosis is usually based on T2 or FLAIR imaging and expert rating. To facilitate precise HOD diagnosis in future studies, we assessed the reliability of this rater-based approach and explored alternative, quantitative analysis.

View Article and Find Full Text PDF

Objectives: Until now, thrombectomy studies have provided little reliable information about the correlation between the infarct topography and clinical outcome of acute stroke patients with embolic large-vessel occlusions. Therefore, we aimed to analyze whether infarcts of the corticospinal tracts in the central white matter (CWM) or the internal capsule on postinterventional imaging controls are associated with poor clinical outcome after thrombectomy.

Materials And Methods: We retrospectively analyzed imaging data from 70 patients who underwent endovascular thrombectomy for emergent middle cerebral artery or carotid-T occlusions.

View Article and Find Full Text PDF

The pH value is a potential physiological marker for clinical diagnosis as it is altered in pathologies such as tumors. While intracellular pH can be measured noninvasively via phosphorus spectroscopy ( P MRSI), Amide Proton Transfer-Chemical Exchange Saturation Transfer (APT-CEST) MRI has been suggested as an alternative method for pH quantification. To assess the suitability of APT-CEST contrast for pH quantification, two approaches (magnetization transfer ratio asymmetry [MTR ] and Lorentzian difference analysis [LDA]) for analyzing the Z-spectrum have been correlated with pH values obtained by P MRSI.

View Article and Find Full Text PDF

Introduction: Magnet resonance imaging (MRI) of gliomas is assessed by Response Assessment in Neuro-Oncology Criteria (RANO), which define new contrast-enhancing lesions as a sign for tumor recurrence. Pseudoprogression after radiotherapy may mimic tumor progression in MRI but is usually limited to the first months after irradiation. We noted a late onset pattern of new contrast-enhancing spots (NCES) appearing years after radiotherapy.

View Article and Find Full Text PDF

In patients with glioblastoma, antiangiogenic therapy with bevacizumab (BEV) has been shown to improve progression-free survival (PFS), but not overall survival (OS). Especially in patients with an unusual infiltrative phenotype as seen in multifocal glioblastoma, the use of BEV therapy is still more controversial. Therefore, we prepared a retrospective case series with 16 patients suffering from a multifocal glioblastoma treated with BEV.

View Article and Find Full Text PDF